SCHEMBL7181896

SCHEMBL7181896

O=C(NC1CCCC1)OCCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.60
EPHX2 P34913 3/20 0.57
RAB9A P51151 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
TSHR P16473 2/20 0.57
TP53 P04637 1/20 0.57
ALDH1A1 P00352 5/20 0.56
GAA P10253 1/20 0.56
TAAR1 Q96RJ0 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
HPGD P15428 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13625190 0.90 EPHX1 (0.65) EPHX1EPHX2RAB9ASMN1; SMN2NPC1
SCHEMBL1690703 0.88 EPHX1 (0.69) EPHX1EPHX2
SCHEMBL11176970 0.87 ALDH1A1 (0.56) EPHX1EPHX2RAB9ASMN1; SMN2NPC1
SCHEMBL23211152 0.85 NAAA (0.48) EPHX1EPHX2RAB9ASMN1; SMN2NPC1
SCHEMBL7198149 0.84 EPHX1 (0.81) EPHX1EPHX2RAB9ATSHRALDH1A1
SCHEMBL8393719 0.83 EPHX1 (0.84) EPHX1EPHX2RAB9ATSHRALDH1A1
SCHEMBL1424064 0.83 EPHX1 (0.84) EPHX1EPHX2RAB9ATSHRALDH1A1
Bicarbonate SCHEMBL6203780 0.82 EPHX1 (0.82) EPHX1EPHX2RAB9ATSHRALDH1A1
Cyclobutylcarbamic Acid Benzyl Ester SCHEMBL332814 0.81 EPHX1 (0.76) EPHX1EPHX2TSHRALDH1A1GAA
Methyl Alcohol SCHEMBL6780968 0.81 EPHX1 (0.80) EPHX1EPHX2RAB9ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322596-A1 ZWITTERIONIC TACHYKININ RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2003-07-02 EP disclosed
WO-2002024629-A1 ZWITTERIONIC TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2002-03-28 WO disclosed